Experimental infection of calves with bovine viral diarrhoea virus type-2 (BVDV-2) isolated from a contaminated vaccine.
A non-cytopathic strain of BVDV-2 was isolated from a batch of live infectious bovine rhinotracheitis (IBR) vaccine, and inoculated intranasally into four 3-month-old calves. Severe signs of disease developed by days 4 and 6 in three of the calves, free of BVDV and antibodies to BVDV, that had been exposed to the virus. These calves survived the acute phase of the infection and progressively recovered. BVDV was consistently isolated, or the respective viral RNA was detected, in the buffy coats from blood samples collected starting from days 2 or 4 up to days 11 or 14 after the experimental infection. Viral RNA was also detected in sera from these infected calves until the presence in the serum of virus neutralizing antibodies was demonstrated. By contrast, the only calf having pre-existing neutralizing antibodies to BVDV at the start of the study was protected from the disease. No virus was detected at any time after experimental inoculation of this calf. Genomic characterization of the BVDV-2 isolated in cell cultures, or detected in sera from the experimentally infected animals, revealed 100%, homology in the nucleotide sequence with the BVDV-2 detected as a contaminant of the live IBR virus vaccine. These findings provided evidence of the infective nature of the contaminant BVDV-2 and of its potential to generate disease outbreaks when inoculated into susceptible animals.
Falcone
E
E
Istituto Superiore di Sanità, Laboratorio di Medicina Veterinaria, Viale Regina Elena 299, 00161 Rome, Italy.
Cordioli
P
P
Tarantino
M
M
Muscillo
M
M
Sala
G
G
La Rosa
G
G
Archetti
I L
IL
Marianelli
C
C
Lombardi
G
G
Tollis
M
M
D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D001483:Base Sequence; D001912:Bovine Virus Diarrhea-Mucosal Disease / Q000097:blood / Q000473:pathology / Q000821:virology*; D002417:Cattle; D030242:Diarrhea Virus 2, Bovine Viral / Q000235:genetics / Q000254:growth & development* / Q000302:isolation & purification; D004340:Drug Contamination; D005260:Female; D007241:Infectious Bovine Rhinotracheitis / Q000276:immunology / Q000517:prevention & control; D007958:Leukocyte Count / Q000662:veterinary; D008969:Molecular Sequence Data; D009500:Neutralization Tests; D010976:Platelet Count / Q000662:veterinary; D012367:RNA, Viral / Q000737:chemistry / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000662:veterinary; D016415:Sequence Alignment; D014611:Vaccination / Q000009:adverse effects / Q000662:veterinary*; D014765:Viral Vaccines / Q000009:adverse effects*
D000914:Antibodies, Viral; D012367:RNA, Viral; D014765:Viral Vaccines